LoginRegister
    Bristol-Myers CEO says Japan restrictive drug price policies risk diverting investmentBristol-Myers CEO says Japan restrictive drug price policies risk diverting investment
    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral LaboratoryDr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory
    Sreeji Gopinathan joins Lupin as Chief Information OfficerSreeji Gopinathan joins Lupin as Chief Information Officer
    Biocon, Mylan launch insulin biosimilar Semglee in AustraliaBiocon, Mylan launch insulin biosimilar Semglee in Australia
    Sub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements: CDSCO CommitteeSub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements:...
    Lupin clears Japanese regulator PMDA inspection of Goa facilityLupin clears Japanese regulator PMDA inspection of Goa facility
    AstraZeneca prostate cancer drug Lynparza shows promiseAstraZeneca prostate cancer drug Lynparza shows promise
    Bayer to improve disease diagnosis, drug design via use of AIBayer to improve disease diagnosis, drug design via use of AI
    4 websites get USFDA warning letter for selling illegal opioid medicines4 websites get USFDA warning letter for selling illegal opioid medicines
    Bangladesh BANS import of raw materials, production, sale of RANITIDINE over cancer fearsBangladesh BANS import of raw materials, production, sale of RANITIDINE over cancer fears
    Pharmacokinetic study of Avastin: Cadila to submit revised protocol to CDSCO committeePharmacokinetic study of Avastin: Cadila to submit revised protocol to CDSCO committee
    Natco Pharma Mekaguda facility gets EIR from USFDANatco Pharma Mekaguda facility gets EIR from USFDA
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X